A new test for endometrial and ovarian cancers, PapSEEK, has been chosen by readers of Québec Science magazine as the 2018 Discovery of the Year. A jury made up of researchers and journalists selects the 10 most impressive discoveries made in Quebec over the previous year for the magazine and the vote is then opened to the public – anyone can cast a ballot for their top choice.
PapSEEK was developed by a team from the Research Institute of the McGill University Health Centre (RI-MUHC) led by Dr. Lucy Gilbert, Director of the Gynecologic Oncology at the MUHC and a professor in the Department of Obstetrics and Gynecology at McGill University and Dr. Kris Jardon, a researcher and gynecologist-oncologist at the RI-MUHC. This work was done in collaboration with researchers at Johns Hopkins University School of Medicine.
“On behalf of the MUHC Foundation, I want to congratulate Dr. Gilbert on this incredible recognition. We are so proud and honoured to support her work. Thanks to the generosity of our donors, it has been our privilege to provide Dr. Gilbert with the financial support required to pursue excellence in research,” states Julie Quenneville, MUHC Foundation President.
Currently, there is no reliable screening test for these types of cancers in women who do not have symptoms. Even when symptoms do appear, they are vague and make diagnosis difficult. Dr. Gilbert is passionate about giving all women access to the early detection test, and helping them beat endometrial and ovarian cancers.
“Over the past 30 years, cure rates for these cancers have stalled because of late diagnosis. There is a need for hope out there, and this Québec Science Award shows that our research is answering that need,” says Dr. Lucy Gilbert.